다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Pharmacology & therapeutics, v.214, 2020년, pp.107613 -
Filardo, Simone (Department of Public Health and Infectious Diseases, Microbiology Section, University of Rome “Sapienza”) , Di Pietro, Marisa , Mastromarino, Paola , Sessa, Rosa
AI-Helper
Abstract Resveratrol has been widely studied for its therapeutic potential due to its antioxidant, anti-inflammatory and anti-microbial properties. In particular, resveratrol has shown promising antiviral activity against numerous viruses responsible for severe respiratory infections. Amongst these...
Adv Virol Abba 2015 2015 10.1155/2015/184241 Antiviral activity of resveratrol against human and animal viruses
Journal of Clinical Virology Alimi 95 26 2017 10.1016/j.jcv.2017.07.019 Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe
Nature Reviews. Drug Discovery Baur 5 493 2006 10.1038/nrd2060 Therapeutic potential of resveratrol: The in vivo evidence
NPJ Precis Oncol Berman 1 2017 The therapeutic potential of resveratrol: A review of clinical trials
International Journal of Molecular Sciences Berretta 21 2945 2020 10.3390/ijms21082945 Resveratrol in cancer patients: From bench to bedside
Nutrition Research Bhatt 32 537 2012 10.1016/j.nutres.2012.06.003 Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
Annals of the New York Academy of Sciences Biasutto 1403 27 2017 10.1111/nyas.13401 Resveratrol derivatives as a pharmacological tool
Pharmacological Research Bo 111 896 2016 10.1016/j.phrs.2016.08.010 Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial
The American Journal of Clinical Nutrition Bode 97 295 2013 10.3945/ajcn.112.049379 In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota
Frontiers in Immunology Bohmwald 10 452 2019 10.3389/fimmu.2019.00452 Contribution of cytokines to tissue damage during human respiratory syncytial virus infection
Cancer Epidemiology, Biomarkers & Prevention Boocock 16 1246 2007 10.1158/1055-9965.EPI-07-0022 Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
Seminars in Diagnostic Pathology Bradley 36 152 2019 10.1053/j.semdp.2019.04.006 Emerging respiratory infections: The infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella
International Journal of Molecular Sciences Breuss 20 1523 2019 10.3390/ijms20071523 Resveratrol and its effects on the vascular system
Endocrine-Related Cancer Carter 21 R209 2014 10.1530/ERC-13-0171 Resveratrol and cancer: Focus on in vivo evidence
Clinics in Chest Medicine Cavallazzi 39 703 2018 10.1016/j.ccm.2018.07.005 Influenza and Viral Pneumonia
Toxicology Letters Chan 161 1 2006 10.1016/j.toxlet.2005.07.010 Dosage effects of resveratrol on ethanol-induced cell death in the human K562 cell line
Autophagy Chen 9 2033 2013 10.4161/auto.26336 Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway
British Journal of Pharmacology Cheng 177 1258 2020 10.1111/bph.14801 Pharmacological basis and new insights of resveratrol action in the cardiovascular system
International Journal of Molecular Sciences Chimento 20 1381 2019 10.3390/ijms20061381 Progress to improve Oral bioavailability and beneficial effects of resveratrol
Molecular Nutrition & Food Research Cottart 54 7 2010 10.1002/mnfr.200900437 Resveratrol bioavailability and toxicity in humans
Journal of Investigative Medicine Dandachi 66 957 2018 10.1136/jim-2018-000712 Viral pneumonia: Etiologies and treatment
Postgraduate Medicine Daoud 131 299 2019 10.1080/00325481.2019.1592400 Pulmonary complications of influenza infection: A targeted narrative review
Frontiers in Immunology Davidson 9 1946 2018 10.3389/fimmu.2018.01946 Treating influenza infection, from now and into the future
Journal of Biological Regulators and Homeostatic Agents Di Pietro 27 509 2013 Resveratrol in Chlamydia pneumoniae-induced foam cell formation and interleukin-17A synthesis
International Journal of Molecular Sciences Di Pietro 18 2017 10.3390/ijms18112459 Infectious agents in atherosclerotic cardiovascular diseases through oxidative stress
Biochemical and Biophysical Research Communications Do 374 55 2008 10.1016/j.bbrc.2008.06.113 Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice
PLoS One Dong 10 2015 Adamantane-resistant influenza A viruses in the world (1902-2013): Frequency and distribution of M2 gene mutations
The Journal of Infectious Diseases Doyle 201 199 2010 10.1086/649559 The interleukin 6174 C/C genotype predicts greater rhinovirus illness
Seminars in Pediatric Infectious Diseases Englund 13 120 2002 10.1053/spid.2002.122999 Antiviral therapy of influenza
Critical Reviews in Clinical Laboratory Sciences Estrela 50 65 2013 10.3109/10408363.2013.805182 Pterostilbene: Biomedical applications
Scientific Reports Euba 7 2017 10.1038/s41598-017-13034-7 Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae
Archives of Virology Farrag 164 1981 2019 10.1007/s00705-019-04300-2 Epidemiology of respiratory viruses in Saudi Arabia: Toward a complete picture
Bioorganic & Medicinal Chemistry Fioravanti 20 5046 2012 10.1016/j.bmc.2012.05.062 Effects of polyphenol compounds on influenza A virus replication and definition of their mechanism of action
Journal of Agricultural and Food Chemistry Francioso 62 1520 2014 10.1021/jf404155e Improved stability of trans-resveratrol in aqueous solutions by carboxymethylated (1,3/1,6)-β-D-glucan
Drug Discovery Today Fulda 15 757 2010 10.1016/j.drudis.2010.07.005 Resveratrol and derivatives for the prevention and treatment of cancer
Oxidative Medicine and Cellular Longevity Gambini 2015 2015 10.1155/2015/837042 Properties of resveratrol: In vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans
Pediatric Allergy and Immunology Gern 13 386 2002 10.1034/j.1399-3038.2002.01093.x Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy
Diabetes & Vascular Disease Research Guo 11 92 2014 10.1177/1479164113520332 Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-kappaB pathway
Medecine et Maladies Infectieuses Haber 48 377 2018 10.1016/j.medmal.2018.01.008 Respiratory syncytial virus infection in elderly adults
Journal of Virology Hastings 89 4405 2015 10.1128/JVI.03275-14 Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication
Frontiers in Immunology Hijano 10 566 2019 10.3389/fimmu.2019.00566 Role of type I interferon (IFN) in the respiratory syncytial virus (RSV) immune response and disease severity
Clinical Microbiology Reviews Jacobs 26 135 2013 10.1128/CMR.00077-12 Human rhinoviruses
Critical Care Kalil 23 2019 10.1186/s13054-019-2539-x Influenza virus-related critical illness: Pathophysiology and epidemiology
Cancer Chemotherapy and Pharmacology Kapetanovic 68 593 2011 10.1007/s00280-010-1525-4 Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats
Antiviral Research Kim 88 227 2010 10.1016/j.antiviral.2010.08.016 Inhibition of influenza virus replication by plant-derived isoquercetin
The Journal of Clinical Endocrinology and Metabolism Kjaer 102 1642 2017 10.1210/jc.2016-2160 No beneficial effects of resveratrol on the metabolic syndrome: A randomized placebo-controlled clinical trial
International Journal of Molecular Sciences Ko 18 2589 2017 10.3390/ijms18122589 The role of resveratrol in Cancer therapy
Infectious Disease Clinics of North America Kodama 31 767 2017 10.1016/j.idc.2017.07.006 Respiratory syncytial virus and other noninfluenza respiratory viruses in older adults
Virus Research Komaravelli 200 19 2015 10.1016/j.virusres.2015.01.018 Role of dietary antioxidants in human metapneumovirus infection
Archives of Virology Kumar 163 831 2018 10.1007/s00705-018-3708-y The emerging influenza virus threat: Status and new prospects for its therapy and control
International Journal of Antimicrobial Agents Lai 55 2020 10.1016/j.ijantimicag.2020.105924 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
Cold Spring Harb Perspect Med pii Lamb 2020 10.1101/cshperspect.a038505 The structure, function, and pathobiology of the influenza A and B virus ion channels
Biochemical Society Transactions de la Lastra 35 1156 2007 10.1042/BST0351156 Resveratrol as an antioxidant and pro-oxidant agent: Mechanisms and clinical implications
The Journal of General Virology Lau 94 2679 2013 10.1099/vir.0.055533-0 Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: Implications for pathogenesis and treatment
Biofouling Lee 35 758 2019 10.1080/08927014.2019.1657418 The anti-biofilm and anti-virulence activities of trans-resveratrol and oxyresveratrol against uropathogenic Escherichia coli
Nature Li 426 450 2003 10.1038/nature02145 Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Food Chemistry Li 135 1239 2012 10.1016/j.foodchem.2012.05.043 Hypohalous acid-mediated halogenation of resveratrol and its role in antioxidant and antimicrobial activities
Scientific Reports Li 17 2018 Characterization of signaling pathways regulating the expression of pro-inflammatory long form thymic stromal lymphopoietin upon human metapneumovirus infection
European Journal of Medicinal Chemistry Li 41 1084 2006 10.1016/j.ejmech.2006.03.024 Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication
PLoS One Lin 10 2015 Polygonum cuspidatum and its active components inhibit replication of the influenza virus through toll-like receptor 9-induced interferon beta expression
Emerg Microbes Infect Lin 9 727 2020 10.1080/22221751.2020.1746199 Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia
BMC Infectious Diseases Lin 17 2017 10.1186/s12879-017-2253-8 Effective inhibition of MERS-CoV infection by resveratrol
Planta Medica Liu 76 1874 2010 10.1055/s-0030-1250030 In vitro anti-influenza viral activities of stilbenoids from the lianas of Gnetum pendulum
Journal of Medical Virology Liu 92 491 2020 10.1002/jmv.25709 Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV
Journal of Virology Liu 88 4229 2014 10.1128/JVI.03637-13 Resveratrol inhibits the TRIF-dependent pathway by upregulating sterile alpha and armadillo motif protein, contributing to anti-inflammatory effects after respiratory syncytial virus infection
Medical Microbiology and Immunology Long 205 459 2016 10.1007/s00430-016-0459-9 NK cells contribute to persistent airway inflammation and AHR during the later stage of RSV infection in mice
Bioscience Trends Lu 16 69 2020 10.5582/bst.2020.01020 Drug treatment options for the 2019-new coronavirus (2019-nCoV)
Geroscience Lushchak 42 117 2020 10.1007/s11357-019-00116-9 Nanodelivery of phytobioactive compounds for treating aging-associated disorders
Makris 2018 Recent advances in understanding rhinovirus immunity. F1000Res
Antiviral Research Mastromarino 123 15 2015 10.1016/j.antiviral.2015.08.010 Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia
The Lancet Respiratory Medicine Mazur 3 888 2015 10.1016/S2213-2600(15)00255-6 Lower respiratory tract infection caused by respiratory syncytial virus: Current management and new therapeutics
MBio Menachery 5 2014 10.1128/mBio.01174-14 Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses
Foods Meng 9 340 2020 10.3390/foods9030340 Health benefits and molecular mechanisms of resveratrol: A narrative review
Am J Pathol Meyerholz 186 78 2016 10.1016/j.ajpath.2015.09.014 Dipeptidyl peptidase 4 distribution in the human respiratory tract: implications for the Middle East respiratory syndrome
Nutrition Militaru 29 178 2013 10.1016/j.nut.2012.07.006 Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: Effects on lipid profiles, inflammation markers, and quality of life
Pediatric Allergy and Immunology Miraglia Del Giudice 25 724 2014 10.1111/pai.12279 Resveratrol plus carboxymethyl-β-glucan may affect respiratory infections in children with allergic rhinitis
International Immunology Misawa 27 425 2015 10.1093/intimm/dxv018 Resveratrol inhibits the acetylated α-tubulin-mediated assembly of the NLRP3-inflammasome
Nutrients Nawaz 9 1188 2017 10.3390/nu9111188 Therapeutic versatility of resveratrol derivatives
The Journal of Infectious Diseases Obando-Pacheco 217 1356 2018 10.1093/infdis/jiy056 Respiratory syncytial virus seasonality: A global overview
The Journal of Infectious Diseases Palamara 191 1719 2005 10.1086/429694 Inhibition of influenza a virus replication by resveratrol
Biomedicine & Pharmacotherapy Pannu 109 2237 2019 10.1016/j.biopha.2018.11.075 Resveratrol: From enhanced biosynthesis and bioavailability to multitargeting chronic diseases
Respirology Park 24 590 2019 10.1111/resp.13558 Respiratory infections assembly of the APSR. Emerging respiratory infections threatening public health in the Asia-Pacific region: A position paper of the Asian Pacific Society of Respirology
Lancet Paules 390 697 2017 10.1016/S0140-6736(17)30129-0 Influenza
Food and Chemical Toxicology Posadino 78 10 2015 10.1016/j.fct.2015.01.017 Resveratrol alters human endothelial cells redox state and causes mitochondrial-dependent cell death
Human Vaccines & Immunotherapeutics Resch 13 2138 2017 10.1080/21645515.2017.1337614 Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection
Pediatric Allergy and Immunology Rossi 28 320 2017 10.1111/pai.12716 Respiratory syncytial virus-host interaction in the pathogenesis of bronchiolitis and its impact on respiratory morbidity in later life
Clinical Microbiology Reviews Russell 30 481 2017 10.1128/CMR.00090-16 The human immune response to respiratory syncytial virus infection
Pathogens Russell 9 E109 2020 10.3390/pathogens9020109 Human Metapneumovirus: A largely unrecognized threat to human health
Colloids and Surfaces. B, Biointerfaces Santos 180 127 2019 10.1016/j.colsurfb.2019.04.030 Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity
Cell Biochemistry and Biophysics Schmatz 65 129 2013 10.1007/s12013-012-9407-5 Moderate red wine and grape juice consumption modulates the hydrolysis of the adenine nucleotides and decreases platelet aggregation in streptozotocin-induced diabetic rats
BMC Complementary and Alternative Medicine Schwager 17 2017 10.1186/s12906-017-1823-z Resveratrol distinctively modulates the inflammatory profiles of immune and endothelial cells
World Journal of Clinical Cases Sessa 2 240 2014 10.12998/wjcc.v2.i7.240 Infectious burden and atherosclerosis: A clinical issue
International Journal of Molecular Sciences Shaito 21 2084 2020 10.3390/ijms21062084 Potential adverse effects of resveratrol: A literature review
Frontiers in Immunology Soto 9 2466 2018 10.3389/fimmu.2018.02466 Human metapneumovirus: Mechanisms and molecular targets used by the virus to avoid the immune system
J Faculty Sci Takaoka 3 1 1940 Phenolic substances of white hellebore (Veratrum grandiflorum Loes. fil.)
Cells Tan 8 986 2019 10.3390/cells8090986 RNA sequencing of H3N2 influenza virus-infected human nasal epithelial cells from multiple subjects reveals molecular pathways associated with tissue injury and complications
Molecular Nutrition & Food Research Tome-Carneiro 56 810 2012 10.1002/mnfr.201100673 Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: A triple-blind, 6-month follow-up, placebo-controlled, randomized trial
The American Journal of Cardiology Tome-Carneiro 110 356 2012 10.1016/j.amjcard.2012.03.030 One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease
Pharmacological Research Tome-Carneiro 72 69 2013 10.1016/j.phrs.2013.03.011 One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease
European Journal of Pharmaceutical Sciences Trotta 86 20 2016 10.1016/j.ejps.2016.02.018 Co-spray dried resveratrol and budesonide inhalation formulation for reducing inflammation and oxidative stress in rat alveolar macrophages
Viruses Vandini 11 521 2019 10.3390/v11060521 Impact of rhinovirus infections in children
Frontiers in Immunology Vazquez 10 1154 2019 10.3389/fimmu.2019.01154 Cytokines in the respiratory airway as biomarkers of severity and prognosis for respiratory syncytial virus infection: An update
International Journal of Antimicrobial Agents Vestergaard 53 716 2019 10.1016/j.ijantimicag.2019.02.015 Antibacterial and antifungal properties of resveratrol
Drug Metabolism and Disposition Walle 32 1377 2004 10.1124/dmd.104.000885 High absorption but very low bioavailability of oral resveratrol in humans
Cell. Walls 2020 10.1016/j.cell.2020.02.058 Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein
Journal of Medical Virology Wang 2020 Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures
British Journal of Pharmacology Xia 174 1633 2017 10.1111/bph.13492 Antioxidant effects of resveratrol in the cardiovascular system
Inflammation Xie 35 1392 2012 10.1007/s10753-012-9452-7 Resveratrol inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells
Bioscience, Biotechnology, and Biochemistry Yang 74 63 2010 10.1271/bbb.90549 Evaluation of resveratrol oxidation in vitro and the crucial role of bicarbonate ions
Respirology Yin 23 130 2018 10.1111/resp.13196 MERS, SARS and other coronaviruses as causes of pneumonia
Diabetes Zang 55 2180 2006 10.2337/db05-1188 Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice
International Immunopharmacology Zang 28 121 2015 10.1016/j.intimp.2015.05.031 Resveratrol suppresses persistent airway inflammation and hyperresponsivess might partially via nerve growth factor in respiratory syncytial virus-infected mice
Journal of Virology Zang 85 13061 2011 10.1128/JVI.05869-11 Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice
European Journal of Pharmaceutics and Biopharmaceutics Zupani 93 196 2015 10.1016/j.ejpb.2015.04.002 Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.